Deferred Tax Assets, Valuation Allowance of DEXCOM INC from 31 Dec 2010 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
DEXCOM INC quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2010 to 31 Dec 2024.
  • DEXCOM INC Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $221,900,000, a 16% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

DEXCOM INC Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $221,900,000 -$42,400,000 -16% 31 Dec 2024 10-K 18 Feb 2025 2024 FY
Q4 2023 $264,300,000 +$185,600,000 +236% 31 Dec 2023 10-K 18 Feb 2025 2024 FY
Q4 2022 $78,700,000 +$8,800,000 +13% 31 Dec 2022 10-K 08 Feb 2024 2023 FY
Q4 2021 $69,900,000 +$14,400,000 +26% 31 Dec 2021 10-K 09 Feb 2023 2022 FY
Q4 2020 $55,500,000 -$276,700,000 -83% 31 Dec 2020 10-K 14 Feb 2022 2021 FY
Q4 2019 $332,200,000 +$2,100,000 +0.64% 31 Dec 2019 10-K 11 Feb 2021 2020 FY
Q4 2018 $330,100,000 +$66,600,000 +25% 31 Dec 2018 10-K 13 Feb 2020 2019 FY
Q4 2017 $263,500,000 +$70,100,000 +36% 31 Dec 2017 10-K 21 Feb 2019 2018 FY
Q4 2016 $193,400,000 -$3,000,000 -1.5% 31 Dec 2016 10-K 27 Feb 2018 2017 FY
Q4 2015 $196,400,000 +$27,400,000 +16% 31 Dec 2015 10-K 28 Feb 2017 2016 FY
Q4 2014 $169,000,000 +$4,300,000 +2.6% 31 Dec 2014 10-K 23 Feb 2016 2015 FY
Q4 2013 $164,700,000 +$13,400,000 +8.9% 31 Dec 2013 10-K 25 Feb 2015 2014 FY
Q4 2012 $151,300,000 +$16,600,000 +12% 31 Dec 2012 10-K 20 Feb 2014 2013 FY
Q4 2011 $134,700,000 +$16,437,000 +14% 31 Dec 2011 10-K 21 Feb 2013 2012 FY
Q4 2010 $118,263,000 31 Dec 2010 10-K 23 Feb 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.